RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Keywords

HydroxychloroquineAzithromycinCoronavirus disease 2019 (COVID-19)MedicineRandomized controlled trial2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Open labelVirologyInternal medicineAntibioticsOutbreakBiologyMicrobiology

Affiliated Institutions

Related Publications

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)

Bindu Bennet , Jayanthi Wolf , Rodrigo Laureano +1 more

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak that started in Wuhan, China, in 2019 resulted in a pandemic not seen for a century, and there is an ur...

2020 Toxicologic Pathology 47 citations

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Chih‐Cheng Lai , Tzu-Ping Shih , Wen‐Chien Ko +2 more

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at ...

2020 International Journal of Antimicrobia... 6277 citations

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen , Di Wu , Wei Guo +17 more

BACKGROUNDSince December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, and is...

2020 Journal of Clinical Investigation 4983 citations

Characteristics of SARS-CoV-2 and COVID-19

Ben Hu , Hua Guo , Peng Zhou +1 more

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute re...

2020 Nature Reviews Microbiology 5269 citations

The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak

Matteo Chinazzi , Jessica T. Davis , Marco Ajelli +13 more

Outbreak to pandemic In response to global dispersion of severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2), quarantine measures have been implemented around the world...

2020 Science 3909 citations

Publication Info

Year: 2020
Type: article
Volume: 56
Issue: 1
Pages: 105949-105949
Citations: 4914
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

4914

OpenAlex

Cite This

APA Style

                            
                                
                                    Philippe Gautret, 
                                
                                    Jean‐Christophe Lagier, 
                                
                                    Philippe Parola
                                
                                et al.
                            
                            (2020). 
                            RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. 
                            International Journal of Antimicrobial Agents
                            , 56
                            (1)
                            , 105949-105949.
                            https://doi.org/10.1016/j.ijantimicag.2020.105949
                        

Identifiers

DOI: 10.1016/j.ijantimicag.2020.105949